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Magnetic Resonance Imaging Stakes a ClaimEike Nagel, MD, PHD,* Y. Chandrashekhar, MD,y Jagat Narula, MD, PHDzR evascularization is not without risk to the pa-tient, and the decision to proceed to percuta-neous coronary intervention begins with
comparing the patient’s individual risk of undergoing
the procedure with the risk of conservative manage-
ment without it. Despite improved understanding,
predicting the risk for stable coronary artery disease
is fraught with many unknowns, especially pertaining
to the relative contributions of ischemia and plaque
burden or their combination. Patients without is-
chemia do not undergo revascularization (1,2),
and those with milder degrees of ischemia may not
beneﬁt from revascularization (3). In contrast, a
greater ischemic burden is associated with a higher
event rate, and these patients beneﬁt from revascu-
larization. However, how much ischemia is needed
before such a beneﬁt is seen remains a matter of
debate. Much of our thinking is based on observa-
tional data, and it is only now being addressed in pro-
spective and randomized trials such as ISCHEMIA
(International Study of Comparative Health Effective-
ness With Medical and Invasive Approaches). Further
investigation is needed to harmonize the deﬁnition of
moderate to severe ischemia with various tests,
because each modality uses its own deﬁnition, and
positive results on different tests may represent
different levels of ischemic burden.
There is also controversy regarding what consti-
tutes ischemia: is the requirement an anatomic ste-
nosis (lumenography), a physiologic stenosis with a
critical threshold of ﬂow limitation (fractional ﬂow
reserve assessment), or an index documenting limitedFrom *King’s College London, London, United Kingdom; yUniversity of
Minnesota, Minneapolis, Minnesota; and the zIcahn School of Medicine,
New York, New York. The authors have reported that they have no
relationships relevant to the contents of this paper to disclose.perfusion (as with perfusion imaging)? Future studies
might even image tissue oxygenation deﬁcit, as in
blood oxygen level–dependent imaging with cardiac
magnetic resonance (CMR). The recently published
PROMISE (Prospective Multicenter Imaging Study for
Evaluation of Chest Pain) trial demonstrates that in
patients with low pre-test likelihood for coronary ar-
tery disease, management guidance by computed
tomographic angiography provides similar outcomes
compared with management guidance by functional
testing. This question will be further addressed by
the MR-INFORM (MR Perfusion Imaging to Guide
Management of Patients With Stable Coronary
Artery Disease) study. This trial will assess whether
clinical management in patients with high pretest
probability can be guided noninvasively by perfu-
sion CMR compared with invasive assessment by
coronary angiography and fractional ﬂow reserve
measurement (4).
Most trials have focused on imaging ﬂow-limiting
stenosis (a focus on ischemia), with negligible em-
phasis on plaque burden. Plaque burden is a marker
of disease severity and has strong prognostic value.
Recent data based on computed tomographic angi-
ography have conﬁrmed the prognostic importance of
plaque burden in a large cohort (5). Stenosis and
plaque burden may even reﬂect different outcomes,
such as the angina- or ischemia-related left ventric-
ular dysfunction with stenosis versus acute events
such as acute coronary syndromes or sudden cardiac
death with plaque burden or plaque characteristics.
What is missing is a pathogenetic link between
ischemia and plaque burden: which is more impor-
tant, and how do these markers relate to each other?
An even more intriguing question is whether the type
of plaque or degree of plaque burden can mediate
or inﬂuence ischemia in non–ﬂow-limiting stenosis.
Recent studies seem to suggest that different types
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751of plaque components can modulate ischemia to
different degrees, probably via endothelial dysfunc-
tion, even in the presence of non–ﬂow-limiting ste-
nosis (6).
Guiding a patient and making a rational thera-
peutic decision also require appropriate markers of
the risk of the procedure. However, the ability to
predict post-procedural outcomes is even more
limited than that to predict disease risk. Methods to
predict a priori which patients will likely leak
troponin post-intervention will thus be of clinical
importance in estimating risk and beneﬁt, but this is
one of the holy grails in cardiology. Although vessel
and lesion anatomy is an important determinant,
early data seem to suggest that plaque burden
and plaque characteristics can also predict post-
procedural outcomes. Currently, risk assessment for
individual patients is dictated mainly by their clin-
ical presentation and the speciﬁc morphologic fac-
tors of lesions themselves observed during invasive
studies. Several scores are available to predict pro-
cedural risk, including the well-known SYNTAX
score. This score is based heavily on lesion location
and complexity, with the presence of thrombus as
visualized by invasive angiography conferring addi-
tional risk. Periprocedural myocardial injury (PMI) is
observed in 5% to 30% of percutaneous coronary
intervention procedures, and in the more severe
cases, it is related to worse outcomes after otherwise
successful revascularization. Even small troponin
leaks have adverse long-term consequences (7). The
risk markers of lesions themselves have been
established with intravascular ultrasound, optical
coherence tomography, and near-infrared spectros-
copy and include the presence and pattern of cal-
cium, the eccentricity of the stenosis, vessel
remodeling, the presence of thrombus, and the
presence of a vulnerable plaque characterized by a
thin cap of the plaque or high intraplaque lipid
burden. Noninvasive markers are evolving (e.g.
napkin ring lesions, a high degree of soft plaque or
extensive calciﬁcation at the lesion site) but these
are still too few, are mostly generic, have very
low positive predictive value, and may inadequately
explain underlying mechanisms.
In this issue of iJACC, Asaumi et al. (8) demon-
strate a relationship between high-intensity coronary
plaques on noncontrast T1-weighted CMR imaging
and PMI during elective coronary intervention. This
observation expands on several previous reports.
A high T1 signal on noncontrast CMR images was
observed in carotid plaques with high lipid or
thrombus burden and was related to a greaterlikelihood of adverse events and worse outcomes (9).
A similar imaging approach has been developed for
the coronary arteries and has demonstrated high
signal in the presence of coronary thrombus (10).
High T1 signal in the coronary arteries also portends
adverse event rates (11). The present paper relates
this observation in coronary arteries to the occur-
rence of PMI. Although this does not yet allow the
prediction of outcomes, the ability to noninvasively
detect an active inﬂamed plaque, thrombus, or
intraplaque lipids, and its relationship with PMI,
opens up an avenue for improved individualized risk
assessment on the basis of noninvasive imaging.
All our efforts so far have been concentrated into
silos and dugouts—individually imaging stenosis or
ischemia or function—as opposed to one comprehen-
sive package—imaging the vessel wall, plaque, and
lumen at the same time. Similarly, we have focused
much on anatomy rather than biology, with only
modest success in reducing hard events. The imaging
of the future will have to integrate anatomy, physi-
ology, and vascular pathology into the decision-
making process, and studies such as this one show
the way. A potential assessment of patients with
stable coronary artery disease in the future might
integrate information from various sources, possibly
multimodal, hopefully noninvasive. Such a pathway
could integrate the presence, severity, and sig-
niﬁcance of myocardial ischemia, the extent and
location of coronary plaque, lesion morphology and
complexity, and plaque stability and risk for emboli-
zation. This knowledge would then be used to
determine an individual patient’s risk for cardiac
events as well as the risk and beneﬁt of a revascu-
larization procedure. Personalized imaging and ther-
apeutics for minimizing individual risk with speciﬁc
therapies, including anti-ischemic drugs to reduce
ischemic burden, heavier antiplatelet coverage, and
targeted-intensity statins to minimize plaque insta-
bility, could logically follow.
Noninvasive plaque imaging and plaque charac-
terization add another parameter to the already
complex ﬁeld of optimizing outcomes in patients with
coronary artery disease. We need more information
on the quantiﬁcation of these parameters and their
relative importance, as well as ways to minimize their
risk, to guide patient management. Thoughtful im-
aging might show the way.
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